Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

  • Log out

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
  • Log out
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Research ArticleOriginal Research

Factors Related to Implementation and Reach of a Pragmatic Multisite Trial: The My Own Health Report (MOHR) Study

Bijal A. Balasubramanian, Suzanne Heurtin-Roberts, Sarah Krasny, Catherine L. Rohweder, Kayla Fair, Tanya T. Olmos-Ochoa, Kurt C. Stange and Sherri Sheinfeld Gorin
The Journal of the American Board of Family Medicine May 2017, 30 (3) 337-349; DOI: https://doi.org/10.3122/jabfm.2017.03.160151
Bijal A. Balasubramanian
From the Department of Epidemiology, Human Genetics & Environmental Science, University of Texas Health Science Center at Houston, School of Public Health, Dallas (BAB); the Implementation Science Team, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville MD (SH-R); Baylor College of Medicine, Houston, TX (SK); UNC Center for Health Promotion and Disease Prevention, University of North Carolina, Chapel Hill (CLR); the Department of Health Promotion and Community Health Sciences, Texas A&M University School of Public Health, Oklahoma City, OK (KF); the Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles (TTO-O); the Departments of Family Medicine & Community Health, Epidemiology & Biostatistics, Sociology, and Oncology, Case Western Reserve University, Cleveland, OH (KCS); and New York Physicians against Cancer (NYPAC), New York (SSG).
MBBS, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suzanne Heurtin-Roberts
From the Department of Epidemiology, Human Genetics & Environmental Science, University of Texas Health Science Center at Houston, School of Public Health, Dallas (BAB); the Implementation Science Team, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville MD (SH-R); Baylor College of Medicine, Houston, TX (SK); UNC Center for Health Promotion and Disease Prevention, University of North Carolina, Chapel Hill (CLR); the Department of Health Promotion and Community Health Sciences, Texas A&M University School of Public Health, Oklahoma City, OK (KF); the Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles (TTO-O); the Departments of Family Medicine & Community Health, Epidemiology & Biostatistics, Sociology, and Oncology, Case Western Reserve University, Cleveland, OH (KCS); and New York Physicians against Cancer (NYPAC), New York (SSG).
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah Krasny
From the Department of Epidemiology, Human Genetics & Environmental Science, University of Texas Health Science Center at Houston, School of Public Health, Dallas (BAB); the Implementation Science Team, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville MD (SH-R); Baylor College of Medicine, Houston, TX (SK); UNC Center for Health Promotion and Disease Prevention, University of North Carolina, Chapel Hill (CLR); the Department of Health Promotion and Community Health Sciences, Texas A&M University School of Public Health, Oklahoma City, OK (KF); the Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles (TTO-O); the Departments of Family Medicine & Community Health, Epidemiology & Biostatistics, Sociology, and Oncology, Case Western Reserve University, Cleveland, OH (KCS); and New York Physicians against Cancer (NYPAC), New York (SSG).
BA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine L. Rohweder
From the Department of Epidemiology, Human Genetics & Environmental Science, University of Texas Health Science Center at Houston, School of Public Health, Dallas (BAB); the Implementation Science Team, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville MD (SH-R); Baylor College of Medicine, Houston, TX (SK); UNC Center for Health Promotion and Disease Prevention, University of North Carolina, Chapel Hill (CLR); the Department of Health Promotion and Community Health Sciences, Texas A&M University School of Public Health, Oklahoma City, OK (KF); the Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles (TTO-O); the Departments of Family Medicine & Community Health, Epidemiology & Biostatistics, Sociology, and Oncology, Case Western Reserve University, Cleveland, OH (KCS); and New York Physicians against Cancer (NYPAC), New York (SSG).
Dr.PH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kayla Fair
From the Department of Epidemiology, Human Genetics & Environmental Science, University of Texas Health Science Center at Houston, School of Public Health, Dallas (BAB); the Implementation Science Team, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville MD (SH-R); Baylor College of Medicine, Houston, TX (SK); UNC Center for Health Promotion and Disease Prevention, University of North Carolina, Chapel Hill (CLR); the Department of Health Promotion and Community Health Sciences, Texas A&M University School of Public Health, Oklahoma City, OK (KF); the Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles (TTO-O); the Departments of Family Medicine & Community Health, Epidemiology & Biostatistics, Sociology, and Oncology, Case Western Reserve University, Cleveland, OH (KCS); and New York Physicians against Cancer (NYPAC), New York (SSG).
RN, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tanya T. Olmos-Ochoa
From the Department of Epidemiology, Human Genetics & Environmental Science, University of Texas Health Science Center at Houston, School of Public Health, Dallas (BAB); the Implementation Science Team, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville MD (SH-R); Baylor College of Medicine, Houston, TX (SK); UNC Center for Health Promotion and Disease Prevention, University of North Carolina, Chapel Hill (CLR); the Department of Health Promotion and Community Health Sciences, Texas A&M University School of Public Health, Oklahoma City, OK (KF); the Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles (TTO-O); the Departments of Family Medicine & Community Health, Epidemiology & Biostatistics, Sociology, and Oncology, Case Western Reserve University, Cleveland, OH (KCS); and New York Physicians against Cancer (NYPAC), New York (SSG).
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kurt C. Stange
From the Department of Epidemiology, Human Genetics & Environmental Science, University of Texas Health Science Center at Houston, School of Public Health, Dallas (BAB); the Implementation Science Team, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville MD (SH-R); Baylor College of Medicine, Houston, TX (SK); UNC Center for Health Promotion and Disease Prevention, University of North Carolina, Chapel Hill (CLR); the Department of Health Promotion and Community Health Sciences, Texas A&M University School of Public Health, Oklahoma City, OK (KF); the Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles (TTO-O); the Departments of Family Medicine & Community Health, Epidemiology & Biostatistics, Sociology, and Oncology, Case Western Reserve University, Cleveland, OH (KCS); and New York Physicians against Cancer (NYPAC), New York (SSG).
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sherri Sheinfeld Gorin
From the Department of Epidemiology, Human Genetics & Environmental Science, University of Texas Health Science Center at Houston, School of Public Health, Dallas (BAB); the Implementation Science Team, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville MD (SH-R); Baylor College of Medicine, Houston, TX (SK); UNC Center for Health Promotion and Disease Prevention, University of North Carolina, Chapel Hill (CLR); the Department of Health Promotion and Community Health Sciences, Texas A&M University School of Public Health, Oklahoma City, OK (KF); the Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles (TTO-O); the Departments of Family Medicine & Community Health, Epidemiology & Biostatistics, Sociology, and Oncology, Case Western Reserve University, Cleveland, OH (KCS); and New York Physicians against Cancer (NYPAC), New York (SSG).
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 30 no. 3 337-349
DOI 
https://doi.org/10.3122/jabfm.2017.03.160151
PubMed 
28484066

Published By 
The Journal of the American Board of Family Medicine
Print ISSN 
1557-2625
Online ISSN 
1558-7118
History 
  • Received for publication May 9, 2016
  • Revision received October 17, 2016
  • Accepted for publication January 23, 2017
  • Published online May 8, 2017.

Copyright & Usage 
© Copyright 2017 by the American Board of Family Medicine.

Author Information

  1. Bijal A. Balasubramanian, MBBS, PhD,
  2. Suzanne Heurtin-Roberts, PhD,
  3. Sarah Krasny, BA,
  4. Catherine L. Rohweder, Dr.PH,
  5. Kayla Fair, RN, MPH,
  6. Tanya T. Olmos-Ochoa, MPH,
  7. Kurt C. Stange, MD, PhD and
  8. Sherri Sheinfeld Gorin, PhD
  9. for the MOHR Study Group
  1. From the Department of Epidemiology, Human Genetics & Environmental Science, University of Texas Health Science Center at Houston, School of Public Health, Dallas (BAB); the Implementation Science Team, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville MD (SH-R); Baylor College of Medicine, Houston, TX (SK); UNC Center for Health Promotion and Disease Prevention, University of North Carolina, Chapel Hill (CLR); the Department of Health Promotion and Community Health Sciences, Texas A&M University School of Public Health, Oklahoma City, OK (KF); the Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles (TTO-O); the Departments of Family Medicine & Community Health, Epidemiology & Biostatistics, Sociology, and Oncology, Case Western Reserve University, Cleveland, OH (KCS); and New York Physicians against Cancer (NYPAC), New York (SSG).
  1. Corresponding author: Bijal A. Balasubramanian, MBBS, PhD, Department of Epidemiology, Human Genetics & Environmental Science, University of Texas Health Science Center at Houston, School of Public Health, 6011 Harry Hines Blvd, V.8.112, Dallas, TX 75390 (E-mail: bijal.a.balasubramanian{at}uth.tmc.edu).
View Full Text

Cited By...

  • 9 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

The Journal of the American Board of Family     Medicine: 30 (3)
The Journal of the American Board of Family Medicine
Vol. 30, Issue 3
May-June 2017
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Factors Related to Implementation and Reach of a Pragmatic Multisite Trial: The My Own Health Report (MOHR) Study
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Factors Related to Implementation and Reach of a Pragmatic Multisite Trial: The My Own Health Report (MOHR) Study
Bijal A. Balasubramanian, Suzanne Heurtin-Roberts, Sarah Krasny, Catherine L. Rohweder, Kayla Fair, Tanya T. Olmos-Ochoa, Kurt C. Stange, Sherri Sheinfeld Gorin
The Journal of the American Board of Family Medicine May 2017, 30 (3) 337-349; DOI: 10.3122/jabfm.2017.03.160151

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Factors Related to Implementation and Reach of a Pragmatic Multisite Trial: The My Own Health Report (MOHR) Study
Bijal A. Balasubramanian, Suzanne Heurtin-Roberts, Sarah Krasny, Catherine L. Rohweder, Kayla Fair, Tanya T. Olmos-Ochoa, Kurt C. Stange, Sherri Sheinfeld Gorin
The Journal of the American Board of Family Medicine May 2017, 30 (3) 337-349; DOI: 10.3122/jabfm.2017.03.160151
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Conclusion
    • Appendix
    • Notes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Dissemination and Implementation Science in Primary Care Research and Practice: Contributions and Opportunities
  • In This Issue: Community Health, Clinical Care, and Clinician Calling
  • Research on Clinical Decisions Made Daily in Family Medicine
  • Google Scholar

More in this TOC Section

  • Associations Between Modifiable Preconception Care Indicators and Pregnancy Outcomes
  • Perceptions and Preferences for Defining Biosimilar Products in Prescription Drug Promotion
  • Evaluating Pragmatism of Lung Cancer Screening Randomized Trials with the PRECIS-2 Tool
Show more Original Research

Similar Articles

Keywords

  • Delivery of Health Care
  • Health Resources
  • Patient Care Team
  • Primary Health Care
  • Quality Improvement

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire